Skip to content
May 23, 2024

Equity.Guru

Investment information for the new generation

Search

MDP.T

Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing a drug candidate from scratch with the very real possibility…
Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing a drug candidate from scratch with the very real possibility…
In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is…
Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing a drug candidate from scratch with the very real possibility…
InnoCan Pharma Corporation, trading on the Canadian Securities Exchange under the symbol INNO, FSE: IP4, and OTC: INNPF, is a pharmaceutical technology company that has garnered attention in the…
In a recent video analysis, Chris Parry from Equity Guru brought to light some intriguing aspects of Medexus Pharmaceuticals (MDP.T), a player in the North American pharmaceutical industry known…
Hey y’all, Lucy Copperpot back for more analysis of Equity.Guru companies – this one is no longer on the client list, but I asked for permission to dig in…
Continuing out Core Story program, today’s exploration is a company we just can’t get enough of, Medexus Pharmaceuticals (MDP.T). CEO Ken D’Entremont has nailed his milestones the last 18…
Medexus Pharma (MDP.T) has made a significant mark in the pharmaceutical industry by focusing on bringing approved drugs from Europe and other jurisdictions to North America. Vishal Toora from…
Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing a drug candidate from scratch with the very real possibility…